These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096 [TBL] [Abstract][Full Text] [Related]
4. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. Roberts KJ; Schrem H; Hodson J; Angelico R; Dasari BVM; Coldham CA; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; Mirza DF HPB (Oxford); 2017 Oct; 19(10):859-867. PubMed ID: 28711377 [TBL] [Abstract][Full Text] [Related]
5. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients. Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656 [TBL] [Abstract][Full Text] [Related]
6. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent. Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer: Validation of an Algorithm for Dose Escalation and Management. Carnie LE; Farrell K; Barratt N; Abraham M; Gillespie L; Satyadas T; McNamara MG; Hubner RA; Geraghty J; Bibby N; Valle JW; Lamarca A Pancreas; 2021 Oct; 50(9):1254-1259. PubMed ID: 34860808 [TBL] [Abstract][Full Text] [Related]
8. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study. Roberts KJ; Bannister CA; Schrem H Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188 [TBL] [Abstract][Full Text] [Related]
9. Dose optimization of pancreatic enzyme replacement therapy is essential to mitigate muscle loss in patients with advanced pancreatic cancer and exocrine pancreatic insufficiency. Klassen PN; Mazurak VC; Baracos V; Martin L; Ghosh S; Kasnik J; Sawyer MB Clin Nutr; 2024 Aug; 43(8):1900-1906. PubMed ID: 38991415 [TBL] [Abstract][Full Text] [Related]
10. Perioperative management of pancreatic exocrine insufficiency-evidence-based proposal for a paradigm shift in pancreatic surgery. Stern L; Schuette M; Goetz MR; Nitschke C; Bardenhagen J; Scognamiglio P; Stüben BO; Calavrezos L; Amin T; Heumann A; Lohse AW; de Heer G; Izbicki JR; Uzunoglu FG HPB (Oxford); 2024 Jan; 26(1):117-124. PubMed ID: 37770362 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy. Chaudhary A; Domínguez-Muñoz JE; Layer P; Lerch MM Dig Dis; 2020; 38(1):53-68. PubMed ID: 31422398 [TBL] [Abstract][Full Text] [Related]
12. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency. Layer P; Kashirskaya N; Gubergrits N World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887 [TBL] [Abstract][Full Text] [Related]
13. Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy in the Treatment of Exocrine Pancreatic Insufficiency. Barkin JA; Harb D; Kort J; Barkin JS Pancreas; 2024 Jan; 53(1):e16-e21. PubMed ID: 38039440 [TBL] [Abstract][Full Text] [Related]
14. Enzyme replacement in advanced pancreatic cancer: patient perceptions. Landers A; McKenzie C; Pitama SG; Brown H BMJ Support Palliat Care; 2023 Oct; 13(e1):e122-e128. PubMed ID: 32201370 [TBL] [Abstract][Full Text] [Related]
15. Adherence to pancreatic enzyme replacement therapy among patients with chronic pancreatitis in East China: a mixed methods study. Zhou Y; Huang RQ; Wu QW; Xu JJ; Yi JH; Chen C; Lu GT; Li ZS; Wang D; Hu LH Sci Rep; 2023 Oct; 13(1):17147. PubMed ID: 37816878 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic enzyme replacement therapy after gastric resection: An update. Antonini F; Crippa S; Falconi M; Macarri G; Pezzilli R Dig Liver Dis; 2018 Jan; 50(1):1-5. PubMed ID: 29170072 [TBL] [Abstract][Full Text] [Related]
17. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes. Lewis DM; Shahid A J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705 [TBL] [Abstract][Full Text] [Related]
18. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer. Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465 [TBL] [Abstract][Full Text] [Related]
19. Pancreatic Enzyme Replacement Therapy in Children with Severe Acute Malnutrition: A Randomized Controlled Trial. Bartels RH; Bourdon C; Potani I; Mhango B; van den Brink DA; Mponda JS; Muller Kobold AC; Bandsma RH; Boele van Hensbroek M; Voskuijl WP J Pediatr; 2017 Nov; 190():85-92.e2. PubMed ID: 28912050 [TBL] [Abstract][Full Text] [Related]
20. Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer. Powell-Brett S; de Liguori Carino N; Roberts K Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):539-544. PubMed ID: 32178962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]